Iterum Therapeutics

Developing therapeutics to treat serious infections from multi-drug resistant bacteria

Iterum Therapeutics is an Ireland-incorporated company developing a clinical-stage therapeutic to treat serious infections resulting from multi-drug resistant bacteria.

Status
IPO in 2018 (NASDAQ: ITRM)
Year of Investment
2015
Strategy
Life Sciences
Location
Ireland